Soliton, Inc. (SOLY) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Houston, TX, アメリカ. 現CEOは Christopher C. Capelli.
SOLY を有する IPO日 2019-02-19, 13 名の正社員, に上場 NASDAQ Capital Marke.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
